© Copyright Nostre Net
Market Highlights
According to MRFR analysis, the global downstream processing market is expected to register a CAGR of~16.09% from 2021 to 2027and hold a value of ~USD 61,174.53million by 2027.
Downstream processing refers to the series of operations required to derive pure and homogeneous protein products from biological materials such as cells, tissue culture fluid, or plant tissues. There is a high demand for the end products extracted by downstream processing, owing to the increasing applicationsin biopharmaceutical products. Thus, the downstream processing market is anticipated to observe significant growth during the forecast period.
Many market players are dominating the global downstream processing market. The prominent players are involved in strategic agreements,new product launches& developments,joint ventures, partnerships, collaborations, mergers & acquisitions, geographic expansionto sustaintheir market positions.For instance, in March 2021, Thermo Fisher Scientific, Inc. (US) announced that more than USD 600 million would be invested to expand its bioprocessing production capabilities through 2022 to meet short-term demands related to COVID-19 as well as long-term efforts to improve new vaccines and biologics for other conditions.
Key Players
Some of the key players in the global downstream processing market are Thermo Fisher Scientific Inc. (US), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), Danaher Corporation (US), 3M Company (US), Boehringer Ingelheim (Germany), Lonza Group AG (Switzerland), Eppendorf AG (Switzerland), Corning Incorporated (US), and Asahi Kasei Corporation (Japan).
Segmentation
The global downstream processing market has been segmented into technique, product, application, and end user.
By technique, the market has been segregated into cell disruption, solid-liquid separation, clarification/concentration, downstream purification techniques, and formulation. The purification techniques segment is further sub-segmented into ion exchange, affinity exchange, hydrophobic interaction, size exclusion chromatography, and others. The purification techniques segment held a significant share of the market in 2020, as it isone of the vital steps in downstream processing and has high product differentiation.
Based on the product, the global downstream processing market has been classified as chromatography columns &resins, filters, membrane adsorbers, and others. The chromatography columns &resinsis one of the most widely used product andwasestimated to bethe largest segment in 2020.
Based on application, the downstream processing market is segmented into antibiotic production, hormone production, antibodies production, vaccine production, and others. Antibiotic productionis one of the vital applications owing to increasing infectious diseases. Furthermore, the ongoing pandemic has created a huge demand for vaccine production globally which further supports the growth of the market.
Based on the end user, the downstream processing market is segmented into biopharmaceutical manufacturers, contract manufacturing organizations, and others. The biopharmaceutical manufacturers segment held the largest market share in 2020 due to increased R&D activities and production of biologics at a largescale, along with the rapidly growing biopharmaceutical industry.
Regional Analysis
By region, North America is anticipated to dominate the global downstream processing market, owing to well-established research organizations involved in research activities, the presence of a high number of contract manufacturing organizations (CMOs), and the presence of a largenumber of pharmaceutical and biopharmaceutical companies. Moreover, the rise in R&D investments by public and private players in the healthcare sectorfurther drives the market growth.
On the other hand, the European downstream processing market is driven by rising R&D expenditure by biopharmaceutical companies, increasing investments in the R&D sector, and the presence of key market players. For instance, in November 2019, Thermo Fisher Scientific, Inc. (US) announced that it is investing nearly USD 24 million in its Scotland site to expand global bioproduction capabilities with additional large-volume liquid manufacturing capacity for cell culture media.
Asia-Pacific is anticipated to be the fastest-growing market in the region over the assessment period due to growing and improving healthcare infrastructure, the establishment of research organizations, and increasing investments in biotechnology. In addition, factors such as the growing investments by key market players and the rapidly developing pharma and biopharma sector in the region are further driving the market.For instance, in April 2021, Asahi Kasei Corporation, a solution provider to the biologics manufacturing industry, expanded its business in China with the launch of Asahi Kasei Bioprocess (Shanghai) Co., Ltd (AKBC).The launch of AKBC facilitates business expansion in China by localizing inventory management and order processing for shorter delivery times.
Furthermore, the growth of the market in theRest of the World is attributed to the booming biotechnology sector and advancements in chromatographic techniques inthe region.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Overview
Tissues, cell lines, and cells are tested, characterized, stored, and collected by the cell banking outsourcing industry. These activities are carried out to aid in the production of biopharmaceuticals as well as research and development activities, ensuring minimal side effects and great efficacy. The technique for cell preservation entails initially proliferating cells, which subsequently multiply into a large number of identical cells, which are then stored in cryovials for future use. The production of regenerative medicine is essentially based on the use of cells. During the projection period of 2021 to 2027, the cell banking outsourcing market is estimated to reach USD 9476.9 million, growing at a CAGR of 15.6%.
Market Trends
During the forecast period, the cell banking outsourcing market is expected to rise due to an increase in the number of cell banks around the world. Another factor projected to drive market growth is the growing number of applications of cell-based products for research and therapeutics. Furthermore, a jump in the number of start-ups focusing on cell-based therapeutics and vaccine production is expected to drive market expansion. Similarly, the growing emphasis on regenerative and customized medicine is expected to fuel growth in the cell banking outsourcing industry. Due to well-established healthcare infrastructure, large patient populations, and significant healthcare expenditures, several key businesses focus on tailoring products and services to the American and European markets. There are no public cord blood banks in Africa, and importing cord blood units from other countries is prohibitively expensive for most patients. With first-to-market advantage, launching subsidiaries in developing regions can be advantageous.
Furthermore, as the prevalence of oncology-related diseases and other infectious chronic diseases rises, cytological R&D, in which cell banking plays a key role, is predicted to develop. Over the projected period, R&D for commercialization of novel characterisation and cryopreservation procedures is expected to significantly boost profitable business potential.
Concerns over sharing of crucial clinical information discovered during the donor screening process, as well as issues around the techniques used to get informed permission from potential cord blood donors, are limiting the expansion of the cell banking outsourcing business.
Competitive Dynamics
The notable players of the market are CordLife (Singapore), Cleancells (France), Charles River Laboratories (US), BSL Bioservice (Germany), BioReliance (US), Sartorius (Germany), Covance (US), LifeCell International Pvt. Ltd. (India), Goodwin Biotechnology Inc. (US), GlobalStem Inc. (US), Cryo-Cell International Inc. (US), Lonza (Switzerland), PX’TherapeuticsSA (France), Wuxi Apptec (China), and the SGS Life Sciences (Switzerland).
Segmental Analysis
The global cell banking outsourcing market is divided into three categories: bank, cell, and application.
The market has been classified into three categories based on bank type: master cell banking, working cell banking, and viral cell banking. Because of its widespread utility, master cell banking is expected to have the largest market share in the worldwide cell banking outsourcing market.
The cell banking outsourcing market has been divided into stem cell banking and non-stem cell banking based on cell type. Because of its growing uses in regenerative medicine, the stem cell banking sector is expected to have the greatest market share in 2021.
Cell bank storage, cell bank preparation, and bank characterization and testing are the application segments of the cell banking outsourcing market.
Regional Overview
North America, Europe, Asia-Pacific, and the rest of the globe are the regions that make up the market.
Because of the greater adoption rates of novel technologies for the manufacturing of vaccines and therapeutic antibodies, North America is expected to have the greatest market share in 2021. Furthermore, the presence of various biopharmaceutical businesses in the region is expected to drive the cell banking outsourcing market in North America to new heights in the near future. North America is also likely to be a lucrative market due to the large number of research and development initiatives related to cytological inquiry for proteomics, genomics, and medication and vaccine development currently underway in the region. The growing demand for vaccines and biopharmaceuticals is expected to boost this region's growth.
The growing prevalence of leukemia in European countries is likely to drive the region's cell banking outsourcing industry forward. Furthermore, the region's cell banking outsourcing market is benefiting from an increase in the number of clinical trials and associations dedicated to discovering a cure for incurable diseases.
The cell banking outsourcing market in Asia-Pacific is predicted to develop at the quickest rate because to the increased prevalence of hematological illnesses, the growth of healthcare facilities, and growing support for the use of stem cell-based therapies. Furthermore, the expansion is likely to be fueled by an increase in the number of favorable government initiatives relating to biotechnology investments. In addition, continuous research and development for cancer therapy and fertility preservation helps to fuel demand for cell banking services.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Overview
Cellulite production has swelled in recent years due to poor nourishment, static postures, dehydration, inflammation, eating habits, alcohol intake, among other factors. The MRFR report predicts that the market will earn a revenue level of USD 1,086.44 million at a CAGR of 8.97% by 2027.
Most corporate employees with cellulite are working on their wellbeing and fitness to amplify their productivity. Resultantly, many firms are partnering with clinics and hospitals to help their staff stay healthy. The cellulite treatment market is motivated by the tremendous influx of female population in metro centers due to employment as younger employees are more health-conscious and press for a better physique to avoid medical problems.
The foremost players in the cellulite treatment market are Nubway (China), Zimmer Aesthetics (Germany), Skinrex Co., Ltd. (South Korea), Cymedics (Germany), Tanceuticals, LLC. (US), Cynosure, Inc. (US), Inceler Medikal Co. Ltd. (Turkey), Syneron Medical Inc (US), Hologic Inc. (US), Cutera (US), Beijing Sincoheren S & T Development Co., Ltd, (China), Candela Medical (US), and Merz Pharma GmbH & Co. KGaA (Germany).
Segmental Analysis
The segmentation of the cellulite treatment market has been conducted based on cellulite type, treatment procedure, region, and end use. The cellulite treatment market is divided into three segments based on end use: specialized dermatological clinics, hospitals, and ambulatory surgical centers. The cellulite treatment market has been segmented based on treatment procedures into minimally invasive, non-invasive, and topical treatment. The cellulite treatment market has been divided into three segments based on cellulite type: soft cellulite, hard cellulite, san francisco cellulite treatment and edematous cellulite. The region segment of the cellulite treatment market includes North America, Asia-Pacific, Europe, and other important regions.
Detailed Regional Analysis
The regional assessment of the cellulite treatment market includes North America, Asia-Pacific, Europe, and other important regions. North America will have the greatest cellulite treatment market share in 2020, owing to well-established product development research groups, the availability of novel treatment products, the consumption of unhealthy diets, and the significant desire for the sculpted figure. The primary players are expanding their operational facilities across the region, collaborating in collaborations and partnerships, and launching new products to drive economic interests. Due to the transformation of healthcare infrastructure, the construction of R&D facilities, and increased awareness about body contouring and physical wellness, the Asia-Pacific cellulite treatment market is estimated to be the fastest regional market.
Competitive Analysis
The continuation of occasional lockdowns in numerous regions may cause the market expansion to be hampered if resources such as labor and supply chains are severely impacted. The global market is expected to diversify in operational techniques as innovative models for operation and delivery are implemented. Government assistance is expected to support worldwide market development in the next years. Due to the return of COVID cases in many locations, the market may exhibit constrained growth. It is projected that the emphasis on accumulating reserves of resources to deal with unexpected crises would impact future market trends. Market developments and research are expected to generate attractive growth opportunities in the next years. The reliance on online commerce for sales is expected to increase significantly during the forecast period, prompting market stakeholders to invest more in its growth.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Highlights
The hydroxychloroquine drug is used in the treatment of malaria. Apart from malaria, it is also used for the treatment of rheumatoid arthritis, lupus erythematosus, and recently discovered COVID-19 disease. Hydroxychloroquine is more preferable than chloroquine as it has fewer side effects.
The growth of the global hydroxychloroquine drug market can be contributed to the growing need for rescue medication, high demand for hydroxychloroquine drugs, due to the outbreak of COVID-19 globally, and increasing prevalence of chronic diseases.
Ipca is the global manufacturer of hydroxychloroquine drugs. Sanofi S.A., Hikma pharmaceuticals, and Concordia Healthcare are some of the competitors that dominate the global hydroxychloroquine market. The key players are involved in awareness campaigns, product approvals, mergers, and strategic collaborations to strengthen their market positions. For instance, according to outsourcing-pharma.com, on 19 May 2020, sterling pharma kicks off hydroxychloroquine production. The US FDA recently lifted import alerts on its plants, paving the way for the firm to export it to the US. Cadila was already exporting it to the US, though the numbers were not huge
Key Players
Some of the key players in hydroxychloroquine market are Zydus Cadila (India), Ipca laboratories (India), Sanofi S.A. (France), Hikma Pharmaceuticals (UK), Novartis International AG (Switzerland), Teva Pharmaceutical, Industries Ltd (Israel), Apotex Corporation (Canada), Mylan N.V. (US), Concordia Healthcare (UK), Amneal Pharmaceuticals, Inc. (US), Taj Pharmaceuticals (India), Sun Pharmaceutical Industries Ltd. (India), Shanghai Pharmaceuticals Holding (China), Hanlim Pharmaceutical (South Korea), Kyung Poong (South Korea), Laurus Labs Limited (India), Covis Pharmaceuticals, Inc. (Switzerland), Lupin Pharmaceutical (India).
Segmentation
The hydroxychloroquine market has been segmented by strength and application
Based on the strength, the hydroxychloroquine market has been segmented into 200mg, 400mg, and others. Among them, 200mg is commonly used to cure arthritis as well as for malaria and recently for COVID-19. 400 mg dosage is commonly used for the treatment of Malaria, Lupus Erythematosus, and Rheumatoid Arthritis once a week for the adults. In addition, the increasing usage of hydroxychloroquine for COVID-19 treatment is driving the growth of the market.
Based on the application, the segment is classified into Coronavirus disease (COVID 19), Malaria, Rheumatoid Arthritis, Lupus Erythematosus, Porphyria cutanea tarda (PCT), Q fever, and others. The malaria segment dominated the global hydroxychloroquine market and held the largest market share in 2019. The hydroxychloroquine is used for the treatment of malaria, which is caused by the mosquito bite. It is a reasonably inexpensive drug and generally sold as over the counter drug in the countries such as India.
Regional Analysis
The market has divided into regions like the Americas, Europe, Asia-Pacific, the Middle East, & Africa. America is further segmented into North America and Latin America. America does not produce anti-malarial drugs, as there is no prevalence of malaria. The outbreak of COVID-19 has increased demand. North America is predicted to be one of the largest markets for hydroxychloroquine in the coming years. The European hydroxychloroquine market has been categorized as western Europe and eastern Europe. Western Europe further classified as Germany, France, the UK, Italy, Spain, and the rest of western Europe. Asia-Pacific is classified as China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. India is the largest manufacturer of antimalarial drugs. The hydroxychloroquine market in the Middle East & Africa is categorized into the Middle East and Africa.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Highlights
A protective mask acts as a device that covers the mouth, nose, or both of a patient who requires positive pressure, non-invasive ventilation, or continuous positive pressure ventilation.
The growth of the healthcare protective masks market can be attributed to the rise in demand due to the COVID-19 epidemic, rising number of surgical procedures, and increasing prevalence of infectious diseases.
Furthermore, the rising prevalence of age-related diseases, mass manufacturing operations in Southeast Asian countries, increasing investments in healthcare facilities, and increasing levels of pollution, are also expected to boost the market during the forecast period.
However, manufacturers providing low-quality face masks, and a rise in prices of face masks are expected to restrain the growth of the healthcare protective masks market.
Several market players such as 3M, Cardinal Health Inc., and Medline Industries Inc. among others currently dominating the global healthcare protective masks market.
Key Players
Some of the key players in the global healthcare protective masks market are 3M (US), Cardinal Health, Inc. (US), Narang Medical Limited (India), Mölnlycke Health Care AB (Sweden), Henry Schein, Inc. (US), Medline Industries, Inc. (US), Sterimed (India), Honeywell International Inc. (US), Kimberly-Clark Corporation (US), Ansell Ltd (Australia), Dynarex Corp. (US)
Regional Analysis
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market, owing to the rise in COVID-19 cases in the region. The healthcare protective masks market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European healthcare protective masks market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The healthcare protective masks market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. Due to the increasing number of surgical procedures, the market in Asia-Pacific is expected to be the fastest-growing. The healthcare protective masks market in the Middle East & Africa has been divided into the Middle East and Africa.
Segmentation
Global Healthcare Protective Masks Market has been segmented based on the Product Type and The End User.
Based on the product type, the global healthcare protective masks have been segmented into surgical masks, anesthesia masks, and respirators. The surgical masks segment is expected to be the largest market segment.
On the basis of end user, the market is segmented into hospitals & clinics, and ambulatory surgical centers. The ambulatory surgical center segment is expected to be the fastest-growing segment.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
Market Overview
The global Neurology Devices Market was worth $9,242 million in 2018 and is predicted to reach $ 17,410 million by 2026, growing at an annual rate of 8.1 per cent between 2019 and 2026. Neurology is a discipline of medicine that focuses on problems with the nervous system, including the brain, blood vessels, muscles, and nerves. The treatment of neurological disorders like Alzheimer's, tumors, and Parkinson's disease with neurovascular devices like interventional devices, cerebrospinal fluid management devices, and others. Shunts, valves, and external drainage systems are also used in cerebrospinal fluid management devices to facilitate the flow of cerebrospinal fluid and remove excess fluid from the brain.
A shunt also provides an alternative fluid conduit by which the cerebrospinal fluid avoids obstacles in the brain's fluid compartments as well as acts whenever fluid absorption is otherwise impeded. The stent-created bypass relieves the extra fluid buildup which causes hydrocephalus. Furthermore, numerous other devices or instruments, like catheters, ultrasonic aspirators, stents, and stereotactic systems, are available on the market for the therapy of neurological devices market.
Key Players
Some of the key players in the global neurology devices market are B. Braun Melsungen AG, Boston Scientific Corporation, Integra LifeSciences Holdings Corporation, Johnson and Johnson, Medtronic Inc., St. Jude Medical, Inc., Stryker Corporation, W.L. Gore & Associates, Inc., and Esaote, among others
Market Segmentation
The cerebrospinal fluid management devices segment dominated the neurology devices market by product in 2018, and this trend is expected to continue over the projected period. It is due to an increase in the use of these devices for neurological device diagnosis. These management devices, for example, are frequently employed in the neurology diagnostics and treatment of multiple sclerosis, encephalitis, myelitis, and other neurological diseases.
The hospital segment captured the most market share by end-user in 2018, and this trend is expected to continue during the projected period. This is due to the simple accessibility of neurological devices in hospital settings and patients' preference for visiting hospitals for neurological device diagnosis and therapy.
Regional Classification
In 2018, the neurology devices market was dominated by North America, followed by Europe. Increased government funding for the R&D of novel neurological devices and a rise in prevalence of neurological disorders like Alzheimer's and Parkinson's disease are driving the overall expansion of the North American neurology devices market. Furthermore, the widespread availability of innovative neurological equipment and a well-developed healthcare infrastructure and the existence of major companies all contribute to the market's development.
However, due to a growth in the frequency of neurological illnesses and the availability of a big patient pool in this region, LAMEA is expected to develop at the fastest pace over the analysis period. Furthermore, major factors driving the area's neurology devices market development include rising per capita income in many nations, increased government initiatives to boost the healthcare sector, as well as a sharp rise in leading manufacturers' focus on expanding their geographic presence in emerging countries to capture the largest share of the neurology devices market.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The Medical Second Opinion Market is expected to reach $7.12 billion by 2025, with a CAGR of 19.1% over the forecast period of 2020-2025. After the original diagnosis, the patient may seek a second opinion from a medical professional. When the patient is unsatisfied with the prognosis or if there is a more need for validation within the case of some critical surgical operations, the patient might request a medical second opinion. Post the original diagnosis; the patient may seek a second opinion from a medical professional. Chronic diseases like ocular disorders, pulmonary disorders, neurological disorders, and nephrological disorders, which are driving the medical second opinion market over the projected period, have a significant need for a second opinion.
Market Segmentation
Medical second opinion depending on disorder kind Cardiac disorder, neurologic disorder, organ transplant, COPD, skin disorder, ocular disorder, kidney, nephrological disorder, urological disorder, and others are some of the market segments. In terms of revenue, the neurological illness segment had the highest share in 2019. It is due to a growing emphasis on lowering healthcare costs and increasing the incidence of neurological illnesses. During the projected period 2020-2025, COPD is expected to increase at the fastest rate of 19.7%. It is due to the rise in the prevalence and incidence of asthma, COPD patients, technological developments, and an ageing population.
The Medical Second Opinion Market is divided into Health Insurance Companies, Hospitals, Online and Offline Second Opinion Service Providers, medical second opinion services, Private Clinics, and Others based on the kind of service provided. In 2019, the hospital segment accounted for the majority of the market. This is due to the convenience they offer patients and the rising prevalence and incidence of technological breakthroughs, asthma and COPD, and the aging population. Throughout the forecast period 2020-2025, the market for online and offline second opinion service providers is expected to develop at the quickest rate. It is due to the increasing number of hospitals and online provider services and increased efficiency and service provider features, all of which are adding to the segment's development.
Regional Classification
The Medical Second Opinion Market is divided into Europe, North America, Asia-Pacific, and the World, depending on geography. In terms of revenue, North America dominated with an overall share of XX percent in 2019. It's due to a well-informed population, advanced healthcare infrastructure, and supportive government policies. During the prediction year 2020-2025, Europe is expected to have the highest CAGR. This is due to a rising need in European nations for enhanced diagnostic and treatment planning and lower financial costs and easier contact.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Scope of the Report
Market Research Future (MRFR) expects the nebulizers market to attain a valuation of USD 1,629.7 Million by the year 2027. It is also presumed that the market size will continue to soar at a rate of 7.32% between 2020 and 2027.
Top Boosters and Key Barriers
The COVID-19 outbreak has interestingly been opportune for the nebulizers industry. The rising cases of SARS-CoV-2 have pushed the demand for albuterol inhalers across hospitals for treating suspected patients suffering from respiratory issues. COVID-19 is a common facilitator of asthma or respiratory exacerbations, with the geriatric population deemed to be more susceptible to these health conditions. This demography is also highly prone to several respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD), novel coronavirus as well as sleep apnea. In a nutshell, the burgeoning elderly population should foster the demand for nebulizers market in the upcoming years.
Drug wastage is one of the biggest challenges faced by the healthcare sector following device usage. Sensing the opportunity, several companies are coming up with highly innovative nebulizers such as vibrating mesh, breath-enhanced and breath-actuated nebulizers that cut down drug wastage and enhance the efficiency of drug delivery. Such nebulizers help elevate the output rate while reducing the entire administration period. Besides, the heightened demand for healthcare devices that can be used at home and the surging consumption of cigarettes, alcohol and tobacco that cause respiratory disorders should also enhance the market size in the years to come.
Companies Profiled
Braun Melsungen AG (Germany), Invacare Corporation (US), Drive DeVilbiss Healthcare (US), Briggs Healthcare (US), GF Health Products, Inc. (US), PARI (US), Agilent Technologies Inc. (US), Koninklijke Philips N.V. (Netherlands), OMRON Healthcare (Japan), Vectura Group PLC (UK), Beurer GmBH (Germany), Rossmax International Ltd (Taiwan), are the prominent firms in the global market.
Segmental Status
The nebulizers industry has been dissected with respect to type, usage, portability along with end user.
The nebulizer types that are available in the global market are jet, ultrasonic as well as mesh. The types of mesh nebulizers include passive and active. From the main types of nebulizers, the jet nebulizers types should procure the top position over the following years since they are far more cost-effective compared to other types in the market and should therefore, note higher demand.
Usage-wise, the major segments can be reusable and disposable. Out of these, the leading spot has been secured by disposable nebulizers, as these witness significant demand given the provision of reduced infection rate as well as wastage.
Portable and tabletop are identified as the main segments, as per portability. The portable nebulizers market has been progressing at the fastest pace, thanks to its convenient coupled with ease of use.
Home care, along with hospitals & clinics are the industry end-users covered in the MRFR study. In light of the expanding patient base, hospitals and clinics have emerged as the leading segment in the market. But, it is likely that the homecare segment will achieve the fastest growth rate in the years ahead.
Regional Status
Europe/EU, the Americas, Asia Pacific/APAC and Middle East and Africa/MEA are the key regions across which the nebulizers market is expected to note growth over the review period.
The American market has emerged the clear winner out of the regions, on account of the alarming growth in respiratory disorders and the favorable reimbursement schemes available in the region. The region’s performance will be further bolstered by the fact that consumers here follow a fast-moving lifestyle and therefore, opt for portable devices that are compact and have multiple advanced features. This scenario is also favored by the escalating cases of asthma and a number of airway diseases in the region.
The European market stands second and is expected to attain higher growth in the coming years, in view of the fast-expanding elderly patient base affected by several respiratory diseases. Frequent technological advances and the emergence of new and more sophisticated nebulizers in the market should be favorable as well.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Overview
Electronic Trial Master File (eTMF) Systems Market is expected to reach a value of USD 1825 Million by 2025, at a CAGR of 13.11% during the assessment period of 2019 to 2025.
Market Dynamics
Electronic Trial Master File Systems have grown in favor across a variety of enterprises, including pharmaceutical and biotechnology firms, in the digital age. The eTMF Systems market is growing in popularity since the novel solution allows customers to get a real-time view of clinical papers and manage them effectively. The global eTMF systems market is growing due to a number of factors, including increased acquisitions, new solution and service deployments, and partnerships by leading market participants, as well as an increase in the number of clinical trial studies.
However, small and medium-sized businesses' budget constraints, as well as a scarcity of experienced people to operate electronic systems, may make such solutions less appealing. As a result, such factors may limit the market's expansion throughout the forecast period.
The etmf clinical trials has changed dramatically as a result of Covid 19. It has heightened the necessity to integrate digital technologies into therapeutic activities in order to reduce reliance on manual processes. The epidemic has provided an opportunity to efficiently and creatively record and maintain clinical trial documents. Organizations have turned to the eTMF systems idea to combine digitalization while handling clinical data to capitalize on the new opportunities in the post-Covid era.
Competitive Dynamics
The notable players of the market are Aurea, Inc. (US), Covance Inc. (US), ePharmaSolutions (US), MasterControl, Inc. (US), Oracle (US), Phlexglobal (UK), SureClinical Inc. (US), TransPerfect (US), Veeva Systems (US), and Wingspan (IQVIA) (US).
Segmental Analysis
The eTMF Systems Market can be divided into two categories based on their components: software and services. Both market categories have been performing well, and they are expected to contribute to the Electronic Trial Master File (eTMF) Systems Market's growth over the anticipated time.
The eTMF Systems Market can be divided into on-premise and web/cloud-based systems based on the deployment model. According to the eTMF Systems Market Forecast, the web/cloud segment will likely be the fastest-growing segment in the near future.
According on the end-user, the eTMF Systems Market can be segmented into contract research organizations, biotechnology and pharmaceutical businesses, and others. Due to the increased demand for exact master file solutions, contract research companies are likely to acquire a significant chunk of the Electronic Trial Master File (eTMF) Systems Market Share throughout the forecasted period.
Regional Overview
The global eTMF Systems Market is segmented into four regions: the Americas, Europe, Asia Pacific, and the Middle East and Africa. The Americas is the most important regional sector in terms of market growth on a worldwide scale. Oracle and Veeva Systems are two key players that control a considerable percentage of the Electronic Trial Master File (eTMF) Systems Market Value.
On a worldwide scale, the European market has been performing admirably. The high level of support from regulatory bodies is one of the market's primary drivers. The adoption of quickly growing technology in the market is one of the primary Electronic Trial Master File (eTMF) Systems market trends that is consistent across various regional sectors.
The Asia Pacific region is expected to perform well in the market over the anticipated period. Due to the rising adoption rate of eTMF software and services in Asian countries, the eTMF systems market in this region is expected to develop at the quickest rate throughout the assessment period.
The Middle East and Africa regional division is the smallest in terms of geographical area. The inadequate development of the region's healthcare infrastructure, as well as a lack of exposure to digital technologies and innovations, are the key factors for the eTMF Systems Market's limited growth. Each geographical division is projected to contribute to global market performance during the forecasted time.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The Global Pain Patch Market size is expected to grow at a higher rate than before. Analysts believe that the market will witness a healthy growth at a CAGR of 4.8% during the forecast period 2019-2025. Market value for the pain patch market at global levels is expected to reach USD29.5 billion by 2025. Pain-relief patches also known as pain patches can be easily purchased from pharmacies. They are available in different types, however, most of the pain patches are used for managing both short-term and long-term pain. This clearly means that a pain patch can be prescribed for both acute and chronic pain conditions. This flexibility and effectiveness helps the companies in the global market for pain patch grow as the demand for these products remains strong throughout the year, and its easy availability has given more boost to the market.
A pain patch market when placed on the skin helps the skin absorb a certain amount of medication which helps prevent or reduce pain. The medication easily gets absorbed into the bloodstream, however the type of medication and patch prescribed by physicians may vary depending on the actual need of the patients and levels of the pain. Prescription based pain patches may include diclofenac epolamine, an anti-inflammatory nonsteroidal drug, a local anesthetic known as lidocaine, and opioid pain medication.
For minor injuries, physicians recommend a pain patch with diclofenac epolamine. This formula helps in reducing and controlling minor pain caused due to muscle strains and sprains. This element falls under the same group as ibuprofen and aspirin. Patients are asked to be careful and not use such patches anywhere on a broken skin. A study published by expert analysts has found that such pain patches can provide pain relief for soft-tissue injuries with few adverse effects.
Pain Patch Market Key Players
Pain Patch Market Segmentation
For the scope of research, analysts have segmented the pain patch market based on type, mode of administration, end users, and therapeutic use.
Pain Patch Market Regional Overview
Industry experts have analyzed the global pain patches market at different levels. The report brings information from across the world and provides key insights into regional pain patch markets from the Americas, which is the largest market in the world for pain patches. The growth here is due to an increasing number of patients with chronic diseases and spinal injury. The report also covers the European market where demand for pain patches is on the rise. Other regional pain patch markets covered in the report are Asia-Pacific and the Middle East and Africa. For each of these regions, analysts have also presented country-level trends, predictions, and market status details along with profiling of key players present in the global pain patch market.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.